A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer - Trial NCT06343181
Access comprehensive clinical trial information for NCT06343181 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruiting. The study focuses on Metastatic Breast Cancer. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
European Institute of Oncology
Timeline & Enrollment
N/A
Oct 03, 2022
Dec 31, 2024
Primary Outcome
Evaluation of factors influencing patients' adherence to medical therapy
Summary
Qualitative observational study with the aim to explore medication adherence in a sample of
 patients with metastatic breast cancer.
 
 Patients with metastatic breast cancer receiving or having received oral oncologic therapy,
 and attending the Division of Medical Senology at the European Institute of Oncology, will be
 included and enrolled in this research project.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06343181
Non-Device Trial